We are studying the safety of using specially selected T-cells to treat young patients with viral infections like Adenovirus and Cytomegalovirus after a stem cell transplant. The trial also aims to see how well this treatment controls symptoms related to these infections.
Health conditions and diseases that the clinical trial is designed to study and treat.
A graft infection occurs when an infection develops in the tissue that has been transplanted, often seen in patients who have received a stem cell transplant. This can lead to serious complications, especially if the infection is caused by viruses like CMV, Adenovirus, or EBV that are resistant to standard treatments.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.